Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03202472 · ClinicalTrials.gov registry record · NA
Radiofrequency Identification Technology in Locating Non-palpable Breast Lesions in Patients Undergoing Surgery
A NA study, sponsored by Jonsson Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT03202472 is a NA study that has completed, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 50 participants.
The verdict
NCT03202472, a NA study, has completed, sponsored by Jonsson Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
This pilot clinical trial studies radiofrequency technology in locating non-palpable breast lesions in patients undergoing surgery. Placing a miniature radiofrequency tag or microchip in the breast lesion before surgery and using a handheld device to guide doctors during surgery may improve surgical outcomes in patients with non-palpable breast lesions.
Interventions
- OTHER Questionnaire Administration
- PROCEDURE Mammography
- DEVICE Implanted Medical Device
- PROCEDURE Ultrasonography
- PROCEDURE Radiofrequency (RFID) -Guided Localization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2017-08-03 |
| Est. Completion | 2019-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03202472
The ClinicalTrials.gov registry entry for NCT03202472 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jonsson Comprehensive Cancer Center, which has 321 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Questionnaire Administration is the first listed.
NCT03202472 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03202472 about?
NCT03202472 is a clinical study titled "Radiofrequency Identification Technology in Locating Non-palpable Breast Lesions in Patients Undergoing Surgery". This pilot clinical trial studies radiofrequency technology in locating non-palpable breast lesions in patients undergoing surgery. Placing a miniature radiofrequency tag or microchip in the breast lesion before surgery and using a handheld device to guide doctors during surgery may improve surgical...
What is the current status of trial NCT03202472?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2017-08-03. Estimated completion is 2019-02-01.
What interventions are being tested in trial NCT03202472?
The interventions under investigation include: Questionnaire Administration (OTHER), Mammography (PROCEDURE), Implanted Medical Device (DEVICE), Ultrasonography (PROCEDURE), Radiofrequency (RFID) -Guided Localization (PROCEDURE).
Who is sponsoring clinical trial NCT03202472?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.